LNAI

Lunai Bioworks Inc. - Common Stock (LNAI)

About Lunai Bioworks Inc. - Common Stock (LNAI)

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Details

Daily high

$1.46

Daily low

$1.23

Price at open

$1.44

52 Week High

$13.28

52 Week Low

$1.21

Market cap

6.3M

Dividend yield

Volume

124,972

Avg. volume

46,675

P/E ratio

-.02

Lunai Bioworks Inc. - Common Stock News